# OnCo record lu177-fap-vg11 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lu177-fap-vg11/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lu177-fap-vg11" ;
  schema:name "177Lu-FAP-VG11"@en ;
  schema:alternateName "FAP-VG11"@en, "177Lu-FAP-VG11 Injection"@en ;
  schema:description "177Lu-FAP-VG11 is an experimental radioactive medicine from VitsGen Therapeutics that targets FAP, a protein on the support cells around many tumours. It is in an early hospital-led trial in China, and the FDA has given it orphan drug status for soft tissue sarcoma."@en ;
  schema:url <https://onco.cc/drugs/lu177-fap-vg11/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.vitsgen.com/News?article_id=151>, <https://clinicaltrials.gov/study/NCT07808177>, <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1153626> ;
  onco:tag "pipeline", "orphan-designation" ;
  onco:modality "Lutetium-177 radioligand" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/lu177-radioligand-therapy/> ;
  onco:targets <https://onco.cc/targets/fap/> ;
  onco:companies <https://onco.cc/companies/vitsgen-therapeutics/> .